hepatitis B hyperimmune globulin

04/01/2009 - "This changed in the late 1980s with the introduction of HBIG, which reduced the incidence of hepatitis B in the transplanted liver to approximately 15-50%, with concomitant improvement in graft and overall survival. "
08/01/2001 - "Long-term IV HBIG is effective in preventing recurrent hepatitis B. "
01/01/2013 - "  ETV combined with HBIG provides effective and safe prophylaxis in preventing hepatitis B recurrence after LDLT."
04/01/1993 - "For hepatitis B, we still believe the efficacy of HBIg, and in which patients with hepatitis B HBIg should be used, remains to be defined. "
01/01/2018 - "This study investigated the incidence of DNHB and clinical outcomes in pediatric LT recipients under HBIG prophylaxis, with or without hepatitis B vaccination. "

10/01/2013 - "In those non-immune patients exposed to HBV, the combination of HBIG plus vaccination provides the best protection against infection. "
01/01/2012 - "Successful clearance of HBV infection within 12 months was achieved in significantly more neonates in the HBIG adjusted therapy group than in the standard therapy group (82.8% vs. 57.4%; x2 = 9.696, P less than 0.05). "
11/20/1975 - " Thus, HBIG appeared effective in suppressing not only disease, but also infection itself. "
08/01/1997 - "In this study, we provide evidence that pretransplantation viral load, but not infection with pmHBV, determines the outcome after OLT in patients on high dose HBIg prophylaxis."
02/01/1997 - "Our study suggests that HBV infection in the uterus may be interrupted using multiple HBIG intramuscularly before delivery without any side effects."

01/01/2023 - "Low-dose HBIG (1560 IU) × 4 days and NA, for HBcAb positive recipients and HBcAb positive donors, appear to be effective in preventing HBV reinfection during the post-LT period. "
02/01/2013 - "In conclusion, SC HBIG for long-term prophylaxis of post-LT HBV reinfection resulted safe, well accepted, and effective in maintaining adequate anti-HBs levels."
01/01/2021 - "The recurrence of HBV was 25% and did not differ between the groups of standard reinfection prophylaxis NA/HBIG (21.1%) and HBIG discontinuation (29.4%); (p = 0.56). "
08/01/2020 - "We evaluated reinfection rate, histological changes, and outcome associated with HBIG discontinuation. "
01/01/2014 - "Of the 50 patients, 24 discontinued HBIG without any HBV graft reinfection during a follow-up period of 26.13 ± 7.05 months. "

12/01/2015 - "This study aims to determine the outcomes of chronic hepatitis B (CHB) patients using an HBIG-free regimen. "
12/28/2022 - "Of the 3 children who had chronic hepatitis B, all had received HBIg at birth and two were fully vaccinated. "
10/01/1994 - "The importance of using critical ratio of HBIG and HBVac is indicated, and future application of this complex for vaccination of low- or nonresponders to the present HBVac, as well as for treatment of chronic hepatitis B patients is discussed."
06/01/2020 - "Patients transplanted for chronic hepatitis B infection should receive life-long nucleos(t)ide analogues, with or without HBIg for effective viral control. "
02/01/2014 - "Compared with the control group, the incidence of HBV intrauterine infection (RR = 0.42, 95 % CI 0.27-0.64, P < 0.0001) and the number of chronic hepatitis B (CHB) infants (RR = 0.44, 95 % CI 0.32-0.61, P < 0.00001) were lower in the HBIG administration group. "

03/01/1987 - "[Hepatitis B virus and epidemiological study on efficacy of HBIG for the prevention of type B hepatitis after accidental exposures among medical staff]."
09/23/2023 - "Despite HBV vaccination and hepatitis B immunoglobulin (HBIG), OBI is common in children and adolescents in high-risk groups."
07/01/2007 - "Long-term low-dose IM and high-dose IV HBIG are equally efficacious with similar survival and early hepatitis recurrence rates. "
11/01/1985 - "This case illustrates the necessity for knowing the results of hepatitis serology before injection of HBIG is given in high risk individuals. "
04/01/1982 - "The expense of laboratory tests is compromised by situations which require the costly HBIG and when the individual is inclined to repeated hepatitis exposure. "